We focused our investigation in the characterization of KMT2A\MLL rearranged AML (KMT2Ar-AML) phosphoproteomics because cells with this karyotype showed distinct phosphoproteomes relative to other poor-risk AML cases. Here, KMT2A is linked to acute myeloid leukemia.